Tradestie Institutional Equity Comparison Engine

IRTC vs AXNX โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

IRTC Overall Edge

IRTC Captures Institutional Edge (3โ€“1 Pillars ยท 9โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to iRhythm Technologies, Inc (IRTC) driven by superior Valuation, Growth & Margin, Options & Structure while AXNX counters with relative strength in Momentum & Technical. Fundamentally, IRTC trades at 61.6x Forward P/E with 4.5% operating margin (+14.9% YoY revenue) versus AXNX at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, IRTC sits in BREAKDOWN (16th %ile IV; Dealer Gamma Walls on Pro) against AXNX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner IRTC
IRTC 61.6x vs AXNX N/M Fwd P/E
Growth & Margin Winner IRTC
Op Margin 4.5% vs N/A ยท YoY +14.9% vs N/A
Momentum & Technical Winner AXNX
1Y -43.4% vs +16.9% ยท 52W Pos 11% vs 50%
Options & Structure Winner IRTC
BREAKDOWN (16th %ile IV) vs UNCLASSIFIED (N/A IV)
IRTC NASDAQ
iRhythm Technologies, Inc
Surgical & Medical Instruments & Apparatus
$94.72
+0.51% 1D
Market Cap $3.2B
1M Return -20.83%
1Y Return -43.35%
Forward P/E 61.6x
Unified AI Score
64.5 / 100 BUY
Tech 92.0 Fund 77.0 Flow 68.0 Mom 70.0
AXNX US Equity
AXNX
Institutional Equity
$0.83
-8.28% 1D
Market Cap N/A
1M Return -26.54%
1Y Return +16.92%
Forward P/E N/M
Unified AI Score
52.1 / 100 HOLD
Tech 50.0 Fund 50.0 Flow 50.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: IRTC -43.35% AXNX +16.92% Spread: +28.98 pp (AXNX Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
IRTC TTM Op. Margin: 4.5% AXNX TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on IRTC vs AXNX. Trailing 12-month operating profitability (IRTC 4.5% vs AXNX N/A) and valuation multiples (IRTC 61.6x vs AXNX N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: IRTC (9) vs AXNX (1)
Institutional Metric IRTC AXNX Criterion Row Winner
Market Capitalization Scale $3.2B N/A Larger Scale IRTC
Trailing P/E Ratio Valuation 56.2x N/M Lower Multiple IRTC
Forward P/E Ratio Valuation 61.6x N/M Lower Multiple IRTC
Revenue Growth (YoY) Growth +14.9% N/A Higher Growth IRTC
Operating Margin (TTM) Profitability 4.5% N/A Higher Margin IRTC
Net Profit Margin Profitability -4.5% N/A Higher Margin IRTC
Return on Equity (ROE) Capital Efficiency -25.8% N/A Higher ROE IRTC
52-Week Range Position Momentum 11% ($83โ€“$192) 50% ($0โ€“$1) Stronger Trend AXNX
Beta / 30D Volatility Risk Regime 0.35ฮฒ ยท 115% Vol N/A Lower Realized Risk IRTC
Unified Institutional Score Composite Signal 64.5 / 100 (BUY) 52.1 / 100 (HOLD) Higher Composite IRTC

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full IRTC vs AXNX Buy Guide
IRTC BREAKDOWN
12d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 16th %ile
IV Regime Compressed (<25th %ile)
Live IRTC Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
AXNX UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live AXNX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither IRTC nor AXNX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.